J.-P. De Backer

764 total citations
16 papers, 667 citations indexed

About

J.-P. De Backer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, J.-P. De Backer has authored 16 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 3 papers in Physiology. Recurrent topics in J.-P. De Backer's work include Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). J.-P. De Backer is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). J.-P. De Backer collaborates with scholars based in Belgium, France and United States. J.-P. De Backer's co-authors include Georges Vauquelin, Patrick Vanderheyden, Jacques De Keyser, Frederik Fierens, Norbert Fraeyman, Giampiero Bricca, Pascal Bousquet, A. Donny Strosberg, Carl André and J.A. Hasrat and has published in prestigious journals such as The EMBO Journal, Biochemical Journal and Brain Research.

In The Last Decade

J.-P. De Backer

16 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-P. De Backer Belgium 12 441 355 99 46 44 16 667
Jean‐Paul De Backer Belgium 21 692 1.6× 644 1.8× 197 2.0× 73 1.6× 69 1.6× 44 1.1k
Laurence S. David Canada 13 387 0.9× 392 1.1× 72 0.7× 107 2.3× 23 0.5× 16 722
S. R. Nahorski United Kingdom 15 379 0.9× 300 0.8× 28 0.3× 106 2.3× 12 0.3× 38 719
Mónica L. Fiszman United States 16 340 0.8× 385 1.1× 77 0.8× 112 2.4× 10 0.2× 28 788
Anne M. Morin United States 13 226 0.5× 256 0.7× 19 0.2× 135 2.9× 17 0.4× 20 516
A. Glässer Italy 14 188 0.4× 174 0.5× 33 0.3× 84 1.8× 11 0.3× 54 559
David Heron Israel 8 308 0.7× 224 0.6× 24 0.2× 128 2.8× 10 0.2× 9 592
S. A. Prestwich United Kingdom 17 652 1.5× 505 1.4× 145 1.5× 153 3.3× 7 0.2× 23 1.0k
H. N. Doods Netherlands 11 589 1.3× 455 1.3× 112 1.1× 152 3.3× 16 0.4× 14 780
S Tucek Czechia 22 1.1k 2.5× 862 2.4× 70 0.7× 171 3.7× 52 1.2× 62 1.5k

Countries citing papers authored by J.-P. De Backer

Since Specialization
Citations

This map shows the geographic impact of J.-P. De Backer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. De Backer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. De Backer more than expected).

Fields of papers citing papers by J.-P. De Backer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. De Backer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. De Backer. The network helps show where J.-P. De Backer may publish in the future.

Co-authorship network of co-authors of J.-P. De Backer

This figure shows the co-authorship network connecting the top 25 collaborators of J.-P. De Backer. A scholar is included among the top collaborators of J.-P. De Backer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-P. De Backer. J.-P. De Backer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Liefde, Isabelle Van, Patrick Vanderheyden, J.-P. De Backer, Guy Ebinger, & Georges Vauquelin. (2001). EFFECTS OF BIBP3226 AND BIBP3435 ON CYTOSOLIC CALCIUM IN NEUROPEPTIDE Y Y1RECEPTOR-TRANSFECTED CHINESE HAMSTER OVARY CELLS AND WILD TYPE CHO-K1 CELLS. Journal of Receptors and Signal Transduction. 21(1). 11–23. 4 indexed citations
2.
Vanderheyden, Patrick, Frederik Fierens, J.-P. De Backer, Norbert Fraeyman, & Georges Vauquelin. (1999). Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO‐K1 cells expressing human angiotensin II AT1 receptors. British Journal of Pharmacology. 126(4). 1057–1065. 135 indexed citations
3.
Vauquelin, Georges, Frederik Fierens, J.-P. De Backer, & Patrick Vanderheyden. (1999). The effects of candesartan on human AT1 receptor-expressing Chinese hamster ovary cells.. PubMed. 10 Suppl 11. S15–7. 5 indexed citations
4.
Vanderheyden, Patrick, Isabelle Van Liefde, J.-P. De Backer, & Georges Vauquelin. (1998). [3H]-BIBP3226 and [3H]-NPY Binding to Intact SK-N-MC Cells and CHO Cells Expressing the Human Y1Receptor. Journal of Receptors and Signal Transduction. 18(4-6). 363–385. 10 indexed citations
5.
Flamez, Anja, Michel Gillard, J.-P. De Backer, Georges Vauquelin, & Michel Noyer. (1997). THE NOVEL ALPHA 2 -ADRENOCEPTOR AGONIST [ 3 H]MIVAZEROL BINDS TO NON-ADRENERGIC BINDING SITES IN HUMAN STRIATUM MEMBRANES THAT ARE DISTINCT FROM IMIDAZOLINE RECEPTORS. Neurochemistry International. 31(1). 125–129. 8 indexed citations
6.
Hasrat, J.A., J.-P. De Backer, Georges Vauquelin, & A. J. Vlietinck. (1997). Medicinal plants in Suriname: screening of plant extracts for receptorbinding activity. Phytomedicine. 4(1). 59–65. 29 indexed citations
7.
Hasrat, J.A., Luc Pieters, J.-P. De Backer, Georges Vauquelin, & Arnold Vlietinck. (1997). Screening of medicinal plants from Suriname for 5-HT1A ligands: Bioactive isoquinoline alkaloids from the fruit of Annona muricata. Phytomedicine. 4(2). 133–140. 43 indexed citations
8.
Herroelen, Luc, J.-P. De Backer, Nadine Wilczak, et al.. (1994). Autoradiographic distribution of D3-type dopamine receptors in human brain using [3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Research. 648(2). 222–228. 84 indexed citations
9.
Bricca, Giampiero, et al.. (1994). Imidazoline receptors, non-adrenergic idazoxan binding sites and α2-adrenoceptors in the human central nervous system. Neuroscience. 59(3). 589–598. 137 indexed citations
10.
Keyser, Jacques De, et al.. (1993). What intracranial tissues in humans contain sumatriptan-sensitive serotonin 5-HT1-type receptors?. Neuroscience Letters. 164(1-2). 63–66. 12 indexed citations
11.
Convents, André, J.-P. De Backer, Carl André, & Georges Vauquelin. (1989). Desensitization of α2-adrenergic receptors in NG 108 15 cells by (–)-adrenaline and phorbol 12-myristate 13-acetate. Biochemical Journal. 262(1). 245–251. 16 indexed citations
12.
Convents, André, et al.. (1987). Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.. Molecular Pharmacology. 32(1). 65–72. 21 indexed citations
13.
Vanderheyden, Patrick, Guy Ebinger, J.-P. De Backer, & Georges Vauquelin. (1986). Identification of M2 muscarinic receptors in membranes from bovine cerebral basal arteries. Life Sciences. 39(17). 1517–1523. 11 indexed citations
14.
André, Camille, J G Guillet, J.-P. De Backer, et al.. (1984). Monoclonal antibodies against the native or denatured forms of muscarinic acetylcholine receptors.. The EMBO Journal. 3(1). 17–21. 79 indexed citations
15.
André, Carl, et al.. (1983). Purification of muscarinic acetylcholine receptors by affinity chromatography.. The EMBO Journal. 2(4). 499–504. 58 indexed citations
16.
André, Carl, Georges Vauquelin, J.-P. De Backer, & A. Donny Strosberg. (1981). Identification and chemical characterisation of β-adrenergic receptors in intact turkey erythrocytes. Biochemical Pharmacology. 30(20). 2787–2795. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026